Background: Lymph node involvement is an important prognostic factor in patients with gastric cancer. The aim of this study was to determine the prognostic significance of metastatic lymph node ratio (MLNR) and compare it to the number of lymph node metastasis in pN3 gastric cancer. Methods: We retrospectively analyzed 207 patients with pN3 gastric cancer who had undergone radical gastrectomy. Prognostic factors and MLNR were evaluated by univariate and multivariate analysis. Results: An MLNR of 0.75 was found to be the best cut-off value to determine the prognosis of patients with pN3 gastric cancer (p = 0.001). The MLNR was significantly higher in patients with large-sized and undifferentiated tumors, vascular, lymphatic and perineural invasion, and total gastrectomy. In multivariate analysis, MLNR (p = 0.041), tumor differentiation (p = 0.046), and vascular invasion (p = 0.012) were found to be independent prognostic factors for disease-free survival, while both MLNR (p < 0.001) and pN stage (p = 0.002) were independent prognostic indicators, as was tumor size, for overall survival. There was significant difference with respect to the recurrence patterns between MLNR groups. Lymph node and peritoneal recurrences were significantly higher in patients with MLNR > 0.75 compared to the MLNR < 0.75 group (p < 0.05). However, recurrence patterns were similar between pN3a and pN3b. Conclusion: Our results showed that MLNR was a useful indicator to determine the prognosis and recurrence patterns of patients with radically resected gastric cancer. Moreover, MLNR is a beneficial and reliable technique for evaluating lymph node metastasis.

1.
Siegel
RL
,
Miller
KD
,
Jemal
A
.
Cancer statistics, 2018
.
CA Cancer J Clin
.
2018
Jan
;
68
(
1
):
7
30
.
[PubMed]
0007-9235
2.
Desai
AM
,
Pareek
M
,
Nightingale
PG
,
Fielding
JW
.
Improving outcomes in gastric cancer over 20 years
.
Gastric Cancer
.
2004
;
7
(
4
):
196
201
.
[PubMed]
1436-3291
3.
Dicken
BJ
,
Bigam
DL
,
Cass
C
,
Mackey
JR
,
Joy
AA
,
Hamilton
SM
.
Gastric adenocarcinoma: review and considerations for future directions
.
Ann Surg
.
2005
Jan
;
241
(
1
):
27
39
.
[PubMed]
0003-4932
4.
Hohenberger
P
,
Gretschel
S
.
Gastric cancer
.
Lancet
.
2003
Jul
;
362
(
9380
):
305
15
.
[PubMed]
0140-6736
5.
Siewert
JR
,
Böttcher
K
,
Stein
HJ
,
Roder
JD
.
Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study
.
Ann Surg
.
1998
Oct
;
228
(
4
):
449
61
.
[PubMed]
0003-4932
6.
Edge
SB
,
Compton
CC
,
Fritz
AG
,
Greene
FL
,
Trotti
A
.
AJCC Cancer Staging Manuel
. 7th ed.
New York
:
Springer
;
2010
.
7.
Marchet
A
,
Mocellin
S
,
Ambrosi
A
,
Morgagni
P
,
Garcea
D
,
Marrelli
D
, et al;
Italian Research Group for Gastric Cancer (IRGGC)
.
The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients
.
Ann Surg
.
2007
Apr
;
245
(
4
):
543
52
.
[PubMed]
0003-4932
8.
Kong
SH
,
Lee
HJ
,
Ahn
HS
,
Kim
JW
,
Kim
WH
,
Lee
KU
, et al
Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging
.
Ann Surg
.
2012
Jan
;
255
(
1
):
50
8
.
[PubMed]
0003-4932
9.
Lee
YC
,
Yang
PJ
,
Zhong
Y
,
Clancy
TE
,
Lin
MT
,
Wang
J
.
Lymph Node Ratio-based Staging System Outperforms the Seventh AJCC System for Gastric Cancer: Validation Analysis With National Taiwan University Hospital Cancer Registry
.
Am J Clin Oncol
.
2017
Feb
;
40
(
1
):
35
41
.
[PubMed]
0277-3732
10.
Wang
J
,
Dang
P
,
Raut
CP
,
Pandalai
PK
,
Maduekwe
UN
,
Rattner
DW
, et al
Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database
.
Ann Surg
.
2012
Mar
;
255
(
3
):
478
85
.
[PubMed]
0003-4932
11.
Wang
W
,
Xu
DZ
,
Li
YF
,
Guan
YX
,
Sun
XW
,
Chen
YB
, et al
Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection--results of a single-institution study of 1343 Chinese patients. Ann Oncol.
2011
; 22: 2049-56.
12.
Maduekwe
UN
,
Lauwers
GY
,
Fernandez-Del-Castillo
C
,
Berger
DL
,
Ferguson
CM
,
Rattner
DW
, et al
New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma
.
Ann Surg Oncol
.
2010
May
;
17
(
5
):
1267
77
.
[PubMed]
1068-9265
13.
Komatsu
S
,
Ichikawa
D
,
Miyamae
M
,
Kosuga
T
,
Okamoto
K
,
Arita
T
, et al
Positive Lymph Node Ratio as an Indicator of Prognosis and Local Tumor Clearance in N3 Gastric Cancer
.
J Gastrointest Surg
.
2016
Sep
;
20
(
9
):
1565
71
.
[PubMed]
1091-255X
14.
Kodera
Y
,
Yamamura
Y
,
Shimizu
Y
,
Torii
A
,
Hirai
T
,
Yasui
K
, et al
Metastatic gastric lymph node rate is a significant prognostic factor for resectable stage IV stomach cancer
.
J Am Coll Surg
.
1997
Jul
;
185
(
1
):
65
9
.
[PubMed]
1072-7515
15.
Takagane
A
,
Terashima
M
,
Abe
K
,
Araya
M
,
Irinoda
T
,
Yonezawa
H
, et al
Evaluation of the ratio of lymph node metastasis as a prognostic factor in patients with gastric cancer
.
Gastric Cancer
.
1999
Aug
;
2
(
2
):
122
8
.
[PubMed]
1436-3291
16.
Nitti
D
,
Marchet
A
,
Olivieri
M
,
Ambrosi
A
,
Mencarelli
R
,
Belluco
C
, et al
Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience
.
Ann Surg Oncol
.
2003
Nov
;
10
(
9
):
1077
85
.
[PubMed]
1068-9265
17.
Bando
E
,
Yonemura
Y
,
Taniguchi
K
,
Fushida
S
,
Fujimura
T
,
Miwa
K
.
Outcome of ratio of lymph node metastasis in gastric carcinoma
.
Ann Surg Oncol
.
2002
Oct
;
9
(
8
):
775
84
.
[PubMed]
1068-9265
18.
Hyung
WJ
,
Noh
SH
,
Yoo
CH
,
Huh
JH
,
Shin
DW
,
Lah
KH
, et al
Prognostic significance of metastatic lymph node ratio in T3 gastric cancer
.
World J Surg
.
2002
Mar
;
26
(
3
):
323
9
.
[PubMed]
0364-2313
19.
Saito
H
,
Fukumoto
Y
,
Osaki
T
,
Yamada
Y
,
Fukuda
K
,
Tatebe
S
, et al
Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer
.
J Surg Oncol
.
2008
Feb
;
97
(
2
):
132
5
.
[PubMed]
0022-4790
20.
Bonenkamp
JJ
,
Hermans
J
,
Sasako
M
,
van de Velde
CJ
,
Welvaart
K
,
Songun
I
, et al;
Dutch Gastric Cancer Group
.
Extended lymph-node dissection for gastric cancer
.
N Engl J Med
.
1999
Mar
;
340
(
12
):
908
14
.
[PubMed]
0028-4793
21.
Inoue
K
,
Nakane
Y
,
Iiyama
H
,
Sato
M
,
Kanbara
T
,
Nakai
K
, et al
The superiority of ratio-based lymph node staging in gastric carcinoma
.
Ann Surg Oncol
.
2002
Jan-Feb
;
9
(
1
):
27
34
.
[PubMed]
1068-9265
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.